Cargando…
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology
The coronavirus disease 2019 (COVID-19) pandemic has consumed our healthcare system, with immediate resource focus on the management of high numbers of critically ill patients. Those that fare poorly with COVID-19 infection more commonly have cardiovascular disease (CVD), hypertension and diabetes....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194073/ https://www.ncbi.nlm.nih.gov/pubmed/32835347 http://dx.doi.org/10.1016/j.ajpc.2020.100009 |
_version_ | 1783528296598732800 |
---|---|
author | Khera, Amit Baum, Seth J. Gluckman, Ty J. Gulati, Martha Martin, Seth S. Michos, Erin D. Navar, Ann Marie Taub, Pam R. Toth, Peter P. Virani, Salim S. Wong, Nathan D. Shapiro, Michael D. |
author_facet | Khera, Amit Baum, Seth J. Gluckman, Ty J. Gulati, Martha Martin, Seth S. Michos, Erin D. Navar, Ann Marie Taub, Pam R. Toth, Peter P. Virani, Salim S. Wong, Nathan D. Shapiro, Michael D. |
author_sort | Khera, Amit |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) pandemic has consumed our healthcare system, with immediate resource focus on the management of high numbers of critically ill patients. Those that fare poorly with COVID-19 infection more commonly have cardiovascular disease (CVD), hypertension and diabetes. There are also several other conditions that raise concern for the welfare of patients with and at high risk for CVD during this pandemic. Traditional ambulatory care is disrupted and many patients are delaying or deferring necessary care, including preventive care. New impediments to medication access and adherence have arisen. Social distancing measures can increase social isolation and alter physical activity and nutrition patterns. Virtually all facility based cardiac rehabilitation programs have temporarily closed. If not promptly addressed, these changes may result in delayed waves of vulnerable patients presenting for urgent and preventable CVD events. Here, we provide several recommendations to mitigate the adverse effects of these disruptions in outpatient care. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers should be continued in patients already taking these medications. Where possible, it is strongly preferred to continue visits via telehealth, and patients should be counselled about promptly reporting new symptoms. Barriers to medication access should be reviewed with patients at every contact, with implementation of strategies to ensure ongoing provision of medications. Team-based care should be leveraged to enhance the continuity of care and adherence to lifestyle recommendations. Patient encounters should include discussion of safe physical activity options and access to healthy food choices. Implementation of adaptive strategies for cardiac rehabilitation is recommended, including home based cardiac rehab, to ensure continuity of this essential service. While the practical implementation of these strategies will vary by local situation, there are a broad range of strategies available to ensure ongoing continuity of care and health preservation for those at higher risk of CVD during the COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-7194073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-71940732020-05-02 Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology Khera, Amit Baum, Seth J. Gluckman, Ty J. Gulati, Martha Martin, Seth S. Michos, Erin D. Navar, Ann Marie Taub, Pam R. Toth, Peter P. Virani, Salim S. Wong, Nathan D. Shapiro, Michael D. Am J Prev Cardiol Clinical Practice Statement The coronavirus disease 2019 (COVID-19) pandemic has consumed our healthcare system, with immediate resource focus on the management of high numbers of critically ill patients. Those that fare poorly with COVID-19 infection more commonly have cardiovascular disease (CVD), hypertension and diabetes. There are also several other conditions that raise concern for the welfare of patients with and at high risk for CVD during this pandemic. Traditional ambulatory care is disrupted and many patients are delaying or deferring necessary care, including preventive care. New impediments to medication access and adherence have arisen. Social distancing measures can increase social isolation and alter physical activity and nutrition patterns. Virtually all facility based cardiac rehabilitation programs have temporarily closed. If not promptly addressed, these changes may result in delayed waves of vulnerable patients presenting for urgent and preventable CVD events. Here, we provide several recommendations to mitigate the adverse effects of these disruptions in outpatient care. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers should be continued in patients already taking these medications. Where possible, it is strongly preferred to continue visits via telehealth, and patients should be counselled about promptly reporting new symptoms. Barriers to medication access should be reviewed with patients at every contact, with implementation of strategies to ensure ongoing provision of medications. Team-based care should be leveraged to enhance the continuity of care and adherence to lifestyle recommendations. Patient encounters should include discussion of safe physical activity options and access to healthy food choices. Implementation of adaptive strategies for cardiac rehabilitation is recommended, including home based cardiac rehab, to ensure continuity of this essential service. While the practical implementation of these strategies will vary by local situation, there are a broad range of strategies available to ensure ongoing continuity of care and health preservation for those at higher risk of CVD during the COVID-19 pandemic. Elsevier 2020-04-30 /pmc/articles/PMC7194073/ /pubmed/32835347 http://dx.doi.org/10.1016/j.ajpc.2020.100009 Text en © 2020 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Clinical Practice Statement Khera, Amit Baum, Seth J. Gluckman, Ty J. Gulati, Martha Martin, Seth S. Michos, Erin D. Navar, Ann Marie Taub, Pam R. Toth, Peter P. Virani, Salim S. Wong, Nathan D. Shapiro, Michael D. Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology |
title | Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology |
title_full | Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology |
title_fullStr | Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology |
title_full_unstemmed | Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology |
title_short | Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology |
title_sort | continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the covid-19 pandemic: a scientific statement from the american society for preventive cardiology |
topic | Clinical Practice Statement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194073/ https://www.ncbi.nlm.nih.gov/pubmed/32835347 http://dx.doi.org/10.1016/j.ajpc.2020.100009 |
work_keys_str_mv | AT kheraamit continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT baumsethj continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT gluckmantyj continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT gulatimartha continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT martinseths continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT michoserind continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT navarannmarie continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT taubpamr continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT tothpeterp continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT viranisalims continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT wongnathand continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology AT shapiromichaeld continuityofcareandoutpatientmanagementforpatientswithandathighriskforcardiovasculardiseaseduringthecovid19pandemicascientificstatementfromtheamericansocietyforpreventivecardiology |